ACM
CLVS
Advent Capital Management’s Clovis Oncology, Inc. CLVS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Hold |
0
| – | – | – | 231 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 225 |
|
|
2018
Q4 | – | Sell |
-5,000
| Closed | -$147K | – | 317 |
|
|
2018
Q3 | $147K | Buy |
+5,000
| New | +$147K | ﹤0.01% | 222 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 291 |
|
|
2017
Q4 | – | Sell |
-5,000
| Closed | -$412K | – | 285 |
|
|
2017
Q3 | $412K | Sell |
5,000
-13,750
| -73% | -$1.13M | 0.01% | 206 |
|
|
2017
Q2 | $1.76M | Buy |
18,750
+13,750
| +275% | +$1.29M | 0.03% | 170 |
|
|
2017
Q1 | $318K | Buy |
+5,000
| New | +$318K | 0.01% | 200 |
|
|
2016
Q4 | – | Sell |
-5,000
| Closed | -$180K | – | 281 |
|
|
2016
Q3 | $180K | Buy |
+5,000
| New | +$180K | ﹤0.01% | 416 |
|
|
2016
Q2 | – | Sell |
-13,900
| Closed | -$267K | – | 455 |
|
|
2016
Q1 | $267K | Buy |
+13,900
| New | +$267K | ﹤0.01% | 346 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 464 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 488 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 483 |
|